Abdominal fat and cardiovascular disease risk – NHLBI study

Organisation: Position: Deadline Date: Location:

abdominalfatwebIncreasing stomach fat – especially the ‘hidden fat’ in the abdomen –and a lower density fat are associated with newly identified and worsening heart disease risk factors, according to a National Heart Lung and Blood Institute study.

These adverse changes in cardiovascular risk were evident over a relatively short period of time and persisted even after accounting for changes in body mass index (BMI) and waist circumference, two commonly used methods to estimate whether someone is a healthy weight or not.

Previous studies have shown that people who carry excess abdominal fat around their midsection – a so-called “spare tire” – tend to face higher risks of heart disease compared to people who have fat elsewhere. This study adds to the growing body of evidence that regional fat deposits are harmful and further suggests that the density of the stomach fat (measured by CT scan) is just as important as how much fat you have. In general, the higher the fat content, the lower the attenuation, or fat density, that is shown on the CT image.

“What’s really interesting is that we show that an increase in the amount of stomach fat and a lower density fat is associated with worse heart disease risk factors – even after accounting for how much weight was gained,” said Dr Caroline Fox, former senior investigator for the National Heart Lung and Blood Institute and the study’s senior researcher. “This hasn’t been shown before.” Fox said the fat density results were particularly strong.

“Measuring fat density is a new measure that we are still working to understand and warrants further investigation,” she said. “We used it as an indirect measure of fat quality and found that lower numbers were linked to greater heart disease risk.”

Fox and her team sought to determine whether there was a link between anatomical changes in belly fat – both its volume (quantity) and density – and changes in a broad array of cardiovascular disease risk factors during the average six-year study period. They reviewed CT scans to assess how much abdominal fat had accumulated, its location and it’s density in 1,106 participants from the Framingham Heart Study who received this imaging as part of a larger study to measure coronary and abdominal aortic calcification.

Participants’ average age was 45 years and 44 percent were women. Both subcutaneous adipose fat, the fat just under the skin, which is often visible “flab” or love handles, and visceral adipose fat, the fat inside the abdominal cavity, were measured. Over the six-year follow-up period, participants had a 22% increase in fat just under the skin and a 45% increase in fat inside the abdominal cavity on average.

In general, increases in the amount of fat and decreases in fat density were correlated with adverse changes in heart disease risk. Each additional pound of fat from baseline to follow up was associated with new onset high blood pressure, high triglycerides and metabolic syndrome. Even though increases in both types of fat were linked to new and worsening cardiovascular disease risk factors, the relationship was even more pronounced for fat inside the abdominal cavity compared to fat just under the skin.

In particular, individuals with greater increases in fat inside the abdominal cavity showed substantial increases in metabolic risk factors including high blood sugar, high triglycerides and low HDL, or good cholesterol. Fox said that higher levels of fat just under the skin may actually be protective because it serves as a “metabolic sink for storing excess fat particles.” Abdominal cavity fat, on the other hand, is thought to be more dangerous.

Overall, associations remained significant even after adjusting for changes in BMI or waist circumference. Researchers also grouped participants into three groups according to abdominal adipose tissue volume and density change; they found that those with greater increases in fat volume and more decreases in fat density had relatively higher incidence of heart disease risk factors.

An accompanying editorial, by Dr James A de Lemos, said the findings support a growing body of literature that suggests identifying the location and type of fat deposits can provide important information about the risk of heart disease not found in the simple BMI measurement.

In terms of next steps, Fox said more work needs to be done to understand fat density, and why and how it is associated with metabolic consequences of obesity (hypertension, abnormal cholesterol, diabetes, inflammation and insulin resistance). As well, it will be important to tease apart how less dense fat, along with simultaneous increases in the amount of fat may spur the development of harmful cardio-metabolic changes.

Because this is an observational study, researchers cannot draw any causal links. Still, previous studies have associated abdomen fat to higher risks of cancer, cardiovascular events and death.

Background: Subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) are associated with adverse cardiometabolic risk profiles.
Objectives: This study explored the degree to which changes in abdominal fat quantity and quality are associated with changes in cardiovascular disease (CVD) risk factors.
Methods: Study participants (n = 1,106; 44.1% women; mean baseline age 45.1 years) were drawn from the Framingham Heart Study Third Generation cohort who participated in the computed tomography (CT) substudy Exams 1 and 2. Participants were followed for 6.1 years on average. Abdominal adipose tissue volume in cm3 and attenuation in Hounsfield units (HU) were determined by CT-acquired abdominal scans.
Results: The mean fat volume change was an increase of 602 cm3 for SAT and an increase of 703 cm3 for VAT; the mean fat attenuation change was a decrease of 5.5 HU for SAT and an increase of 0.07 HU for VAT. An increase in fat volume and decrease in fat attenuation were associated with adverse changes in CVD risk factors. An additional 500 cm3 increase in fat volume was associated with incident hypertension (odds ratio [OR]: 1.21 for SAT; OR: 1.30 for VAT), hypertriglyceridemia (OR: 1.15 for SAT; OR: 1.56 for VAT), and metabolic syndrome (OR: 1.43 for SAT; OR: 1.82 for VAT; all p < 0.05). Similar trends were observed for each additional 5 HU decrease in abdominal adipose tissue attenuation. Most associations remained significant even after further accounting for body mass index change, waist circumference change, or respective abdominal adipose tissue volumes.
Conclusions: Increasing accumulation of fat quantity and decreasing fat attenuation are associated with worsening of CVD risk factors beyond the associations with generalized adiposity, central adiposity, or respective adipose tissue volumes.

Jane J Lee, Alison Pedley, Udo Hoffmann, Joseph M Massaro, Caroline S Fox

Science Daily report
Journal of the American College of Cardiology abstract

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.